KRSNAA NSE filing

Krsnaa Diagnostics Updates Key Managerial Personnel List

The RealCase readLow impact Neutral

Krsnaa Diagnostics Limited has updated its list of Key Managerial Personnel (KMPs) for materiality assessments and disclosures. The list includes Managing Director Mr. Yash Mutha and Group CEO Mr. Mitesh Dave. This information is available on the company's website and was submitted to stock exchanges on February 5, 2026.

Why it matters

This is a standard disclosure of KMP information for regulatory compliance and is unlikely to have a significant impact on the company's operations or stock price.

The market read

The announcement is a routine regulatory filing regarding the list of Key Managerial Personnel and does not contain any information that would positively or negatively impact the company's stock.

Krsnaa Diagnostics Limited has submitted a list of its Key Managerial Personnel (KMPs) to BSE Limited and the National Stock Exchange of India Limited. This list is intended for determining the materiality of events or information and making necessary disclosures to the stock exchanges, in accordance with the company's policy.

The updated list of KMPs, including their names and designations, has been made available on the company's website. The announcement was made on February 05, 2026, and references Regulation 30(5) of the SEBI Listing Regulations. The company has requested that this information be taken on record by the stock exchanges.

Key personnel listed include Mr. Yash Mutha as Managing Director and Mr. Mitesh Dave as Group Chief Executive Officer, along with their contact details.

Filing to action

What to do with a filing like this

Krsnaa Diagnostics Limited filed this with the NSE as a statutory disclosure, categorised under key management changes. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Krsnaa Diagnostics Limited. Read the original for the full detail.

View original filing